BCSC Blog

High-Risk Benign Breast Disease Is Increasingly Detected with 3D Mammography: New Insights from the BCSC

A new Breast Cancer Surveillance Consortium (BCSC) study provides national estimates of high-risk benign breast disease detection and reveals how mammography technology has influenced detection patterns over the past two decades.

Posted by Sprague, Brian, PhD at 11:15 AM on Nov 20, 2026

Share:


High-risk benign breast disease (BBD) includes a variety of noncancerous breast conditions associated with increased future breast cancer risk. These diagnoses include atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), radial sclerosing lesions, and atypical papillary lesions. Although these conditions are not breast cancer, their identification leads to important clinical management questions, including whether to recommend surgical excision, enhanced imaging surveillance, or preventive medications.

Relatively little is known about how frequently these conditions are detected during routine screening mammography in the United States, or how detection rates have changed with the introduction of newer mammography technologies. A new study from the Breast Cancer Surveillance Consortium (BCSC) examined trends in high-risk BBD detection over nearly two decades and evaluated whether detection differs between digital mammography and digital breast tomosynthesis (DBT), commonly known as 3D mammography.

Researchers analyzed nearly 4.5 million screening mammograms performed among approximately 1.2 million women aged 40–79 years at 97 health care facilities participating in the BCSC between 2005 and 2022.

Several important findings emerged:

  • High-risk benign breast disease is detected in approximately 1 out of every 900 screening mammograms. The overall detection rate was 1.11 per 1,000 examinations, comparable to the detection rate for ductal carcinoma in situ (DCIS).
  • Detection patterns have changed substantially over time. Detection of radial sclerosing lesions increased by approximately 5% annually, while detection of atypical papillary lesions increased by approximately 19% annually. In contrast, detection of ADH declined between 2009 and 2017.
  • 3D mammography is associated with increased detection of high-risk benign breast disease. Compared with conventional digital mammography, DBT was associated with 36% higher odds of detecting high-risk BBD overall. The difference was particularly notable for radial sclerosing lesions, for which detection was more than twice as likely with DBT.

These findings suggest that advances in mammography technology have implications beyond the detection of breast cancer. DBT improves visualization of breast structures and may make certain abnormalities, particularly architectural distortions associated with radial sclerosing lesions, easier to identify. As DBT has become the predominant screening technology in the United States, clinicians are increasingly encountering these diagnoses.

Our findings highlight the need for additional research to determine which women with high-risk benign breast disease benefit from surgical excision versus active surveillance, and how these diagnoses should influence long-term breast cancer risk assessment and prevention strategies. As screening technology continues to evolve, understanding the consequences of increased detection will be essential to ensuring that women receive appropriate, individualized care.

Sprague, B.L., Ponzini, M., Sattayapiwat, O., et al. Temporal Trends in High-Risk Benign Breast Disease Detection at Screening Mammography: Results from the Breast Cancer Surveillance Consortium. Radiology. 2026;321(2):e260889. [link]

The full article can be found here:

Radiology

Media:

Aunt Minnie

By: Sprague, Brian, PhD